Daniel Sheinson
Genesys (United States)(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Health Systems, Economic Evaluations, Quality of Life, Cancer Genomics and Diagnostics, Multiple Sclerosis Research Studies, Economic and Financial Impacts of Cancer
Most-Cited Works
- → TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells(2018)5,347 cited
- → Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model(2017)76 cited
- → A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States(2021)64 cited
- → Association Between Medicare's National Coverage Determination and Utilization of Next-Generation Sequencing(2021)41 cited
- → Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination(2021)41 cited
- → Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients(2019)41 cited
- → <p>Five-Year Patterns of Diabetic Retinopathy Progression in US Clinical Practice</p>(2020)38 cited
- → Comparison of the performance of particle filter algorithms applied to tracking of a disease epidemic(2014)34 cited
- → Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder(2021)25 cited
- → The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis(2022)24 cited